J Korean Diabetes.  2015 Dec;16(4):293-302. 10.4093/jkd.2015.16.4.293.

Economic Evaluation of Diabetes Education

• Noh JW
• Kwon YD
• Jung JH
• Sim KH
• Kim HS
• Choi M
• Park J

• KMID: 2173857
• DOI: http://doi.org/10.4093/jkd.2015.16.4.293

Abstract

BACKGROUND
Diabetes education, also known as diabetes self-management training or diabetes selfmanagement education, is effective in helping patients with diabetes control their illness and maximize their health. However, there is no established institutional strategy in South Korea because economic evaluations of the benefits and costs of diabetes education have been limited. The purpose of this study is two-fold: (1) describe economic evaluation methodologies, one of the tools available to help choose wisely from a range of alternatives and implement effective resources; and (2) suggest applications of economic evaluation in terms of diabetes education.
METHODS
There are three types of commonly used economic evaluations in diabetes education: cost benefit analysis, cost effective analysis, and cost utility analysis.
RESULTS
The understanding of the economic value of diabetes education for people with diabetes has a number of uses: to provide empirical evidence to influence policy-making in diabetes education, to offer proof of the benefits of diabetes self-management, to improve awareness of the importance and necessity of diabetes education, to reduce costs of diabetes management, and to enhance healthcare quality.
CONCLUSION
Further research is needed to evaluate the economic benefits and costs associated with diabetes education.

Keyword

Cost-benefit analysis; Diabetes education; Diabetes management

MeSH Terms

Cost-Benefit Analysis
Education*
Evaluation Studies as Topic
Humans
Korea
Quality of Health Care
Self Care

Reference

References

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27:1047–53.

2. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006; 368:1681–8.

3. Moon EJ, Jo YE, Park TC, Kim YK, Jung SH, Kim HJ, Kim DJ, Chung YS, Lee KW. Clinical characteristics and direct medical costs of type 2 diabetic patients. Korean Diabetes J. 2008; 32:358–65.

4. Park IB, Baik SH. Epidemiologic characteristics of diabetes mellitus in Korea: current status of diabetic patients using Korean health insurance database. Korean Diabetes J. 2009; 33:357–62.

5. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321:405–12.

6. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358:580–91.

7. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359:1577–89.

8. Chiu CJ, Wray LA. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis. 2010; 7:A08.

9. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a metaanalysis of the effect on glycemic control. Diabetes Care. 2002; 25:1159–71.

10. Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM, Weinger K, Weiss MA. National standards for diabetes self-management education. Diabetes Care. 2012; 35(Suppl 1):S101–8.

11. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003; 26(Suppl 1):S33–50.

12. Gagliardino JJ, Aschner P, Baik SH, Chan J, Chantelot JM, Ilkova H, Ramachandran A. IDMPS investigators. Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab. 2012; 38:128–34.

13. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes. 2004; 22:123–7.

14. Peeples M, Tomky D, Mulcahy K, Peyrot M, Siminerio L. AADE Outcomes Project and AADE/UMPC Diabetes Education Outcomes Project. Evolution of the American Association of Diabetes Educators' diabetes education outcomes project. Diabetes Edu. 2007; 33:794–817.

15. Duncan I, Ahmed T, Li QE, Stetson B, Ruggiero L, Burton K, Rosenthal D, Fitzner K. Assessing the value of the diabetes educator. Diabetes Educ. 2011; 37:638–57.

16. Boren SA, Fitzner KA, Panhalkar PS, Specker JE. Costs and benefits associated with diabetes education: a review of the literature. Diabetes Educ. 2009; 35:72–96.

17. Brownson CA, Hoerger TJ, Fisher EB, Kilpatrick KE. Cost-effectiveness of diabetes self-management programs in community primary care settings. Diabetes Educ. 2009; 35:761–9.

18. Yuan C, Lai CW, Chan LW, Chow M, Law HK, Ying M. The effect of diabetes self-management education on body weight, glycemic control, and other metabolic markers in patients with type 2 diabetes mellitus. J Diabetes Res. 2014; 2014:789761.

19. Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC, Davies MJ. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ. 2010; 341:c4093.

20. Dijkstra RF, Niessen LW, Braspenning JC, Adang E, Grol RT. Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis. Diabet Med. 2006; 23:164–70.

21. Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, Cobden D, Nicklasson L, Philis-Tsimikas A, Palmer AJ. Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res. 2007; 42:1943–59.

22. Trento M, Passera P, Borgo E, Tomalino M, Bajardi M, Brescianini A, Tomelini M, Giuliano S, Cavallo F, Miselli V, Bondonio P, Porta M. A 3-year prospective randomized controlled clinical trial of group care in type 1 diabetes. Nutr Metab Cardiovasc Dis. 2005; 15:293–301.

23. Gozzoli V, Palmer AJ, Brandt A, Spinas GA. Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting. Swiss Med Wkly. 2001; 131:303–10.

24. Segal L, Dalton AC, Richardson J. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus. Health Promot Int. 1988; 13:197–209.

25. Lee KS, Lee SI, Koo HW, Park BJ. Issues in introducing pharmaceutical economic evaluation into National Health Insurance scheme in Korea: lessons from European experience. J Korean Soc Clin Pharmacol Ther. 2004; 12:79–92.

26. Kaplan RM, Atkins CJ, Wilson DK. The cost-utility of diet and exercise interventions in non-insulin dependent diabetes mellitus. Health Promot Int. 1987; 2:331–40.

27. Kim H. Role of diabetes educators and effectiveness of diabetes education. J Korean Diabetes. 2013; 14:194–8.

28. Sachmechi I, Wang A, Kim P, Reich D, Payne H, Salvador VB. Impact of diabetes education and peer support group on the metabolic parameters of patients with diabetes mellitus (type 1 and type 2). Br J Med Pract. 2013; 6:a635.

29. Chang KS, Lee K, Lim HS. Glycemic control and health behaviors through diabetes mellitus education in a clinic. J Korean Diabetes Assoc. 2006; 30:73–81.